Association of components of the metabolic syndrome with the appearance of aggregated red blood cells in the peripheral blood. An unfavorable hemorheological finding

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 2, 2005, Pages 197-202

  Toker, Sharon ^a,b   Rogowski, Ori ^a   Melamed, Samuel ^a,c   Shirom, Arie ^a   Shapira, Itzhak ^b   Berliner, Shlomo ^b   Zeltser, David ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c Occupational Health and Rehabilitation Institute Israel   (Israel)

Author keywords

Erythrocyte aggregation; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HEMOGLOBIN;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BLOOD RHEOLOGY; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MACROMOLECULE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK FACTOR;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; FEMALE; HEMORHEOLOGY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 16344375237     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.502     Document Type: Article

References (56)

1. Scott CL. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2003; 92 Suppl. 1): 35-42.
2. Wilson PW, Grundy SM. The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation 2003; 108: 1422-1424.
3. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168: 351-358.
4. Tracy RP. Inflammation, the metabolic syndrome and cardiovascular risk. Int J Clin Pract Suppl 2003; 134: 10-17.
5. Justo D, Marilus R, Mardi T, et al. The appearance of aggregated erythrocytes in the peripheral blood of individuals with insulin resistance. Diabetes Metab Res Rev 2003; 19: 386-391.
6. Talstad I, Scheie P, Dalen H, Roli J. Influence of plasma proteins on erythrocyte morphology and sedimentation. Scand J Haematol 1983; 31: 478-484.
7. Imaizumi K, Shiga T. Effect of immunoglobulins and IgG-fragments on the human erythrocyte aggregation, studied by rheoscope combined with image analyzer. Biorheology 1983; 20: 569-577.
8. Weng X, Cloutier G, Beaulieu R, Roederer GO. Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol 1996; 271: H2346-H2352.
9. Weng X, Roederer GO, Beaulieu R, Cloutier G. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals. Thromb Haemost 1998; 80: 903-908.
10. 2-permeable tube: effects of erythrocyte aggregation. Am J Physiol Heart Circ Physiol 2001; 281: H448-H456.
11. Tateishi N, Suzuki Y, Shirai M, Cicha I, Maeda N. Reduced oxygen release from erythrocytes by the acceleration-induced flow shift, observed in an oxygen-permeable narrow tube. J Biomech 2002; 35 1241-1251.
12. Baskurt OK, Yalcin O, Ozdem S, Armstrong JK, Meiselman HJ. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 2004; 286: H222-H229.
13. Cohen S, Tolshinsky T, Rogowski O, et al. Real time, control adjusted evaluation of intensity of the inflammatory response. J Inform Tech Healthcare 2003; 1: 195-207.
14. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Heart, Lung and Blood Institute, NIH Publication No 01-3670, 2001.
15. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 1965; 2: 235-254.
16. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel 1957; 17: 237-246.
17. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136-2141.
18. Zeltser D, Rogowski O, Berliner S, et al. Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and apparently health people. Heart 2004; 90: 277-281.
19. Berliner S, Rogowski O, Aharonov S, et al. Erythrocyte adhesiveness/aggregation. A novel biomarker for the detection of low grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J; (in press).
20. Rotstein R, Landau T, Twig A, et al. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the low grade subclinical smoldering inflammation individuals with atherosclerotic risk factors. Atherosclerosis 2002; 165: 343-351.
21. Rotstein R, Fusman R, Zeltser D, et al. The picture of inflammation: a new concept that combines the white blood cell count and erythrocyte sedimentation rate into a new hematologic diagnostic modality. Acta Haematol 2001; 106: 106-114.
22. Sharshun Y, Brill S, Mardi T, et al. Inflammation at a glance: erythrocyte adhesiveness/aggregation to reveal the presence of inflammation in individuals with atherothrombosis. Heart Dis 2003; 5: 182-183.
23. Berliner S, Shapira I, Rogowski O, et al. Combined leukocyte and erythrocyte aggregation in the peripheral venous blood during sepsis. A clue to the presence of a commonly shared adhesive protein(s). Int J Clin Lab Res 2000; 30: 27-31.
24. Festa A, D'Argostino RB, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resitance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 104: 42-47.
25. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000; 23: 1835-1839.
26. Jialal I, Devaraj S. Inflammation and atherosclerosis: the value of high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 2001; 116(Suppl): S108-S115.
27. Brunner EJ, Hemingway H, Walker BR, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002; 106: 2659-2665.
28. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391-397.
29. Ben Ami R, Barshtein G, Zeltser D, et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol 2001; 280: H1982-H1988.
30. Ben Ami R, Barshtein G, Mardi T, et al. A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol 2003; 285: H2663-H2669.
31. Fusman G, Mardi T, Justo D, et al. Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol 2002; 90: 561-563.
32. Gamzu R, Rotstein R, Fusman R, Zeltser D, Berliner AS, Kupferminc MJ. Increased erythrocyte adhesiveness and aggregation in peripheral venous blood of women with pregnancy-induced hypertension. Obstet Gynecol 2001; 98: 307-312.
33. Levin I, Gamzu R, Hasson Y, et al. Increased erythrocyte aggregation in ovarian hyperstimulation syndrome: a possible contributing factor in the pathophysiology of this disease. Hum Reprod 2004; 19: 1076-1080.
34. Rogowski O, Zeltser D, Rotstein R, et al. Correlated expression of adhesive properties for both white and red blood cells during inflammation. Biorheology 2000; 37: 361-370.
35. Rotstein R, Zeltser D, Shapira I, et al. An inflammation meter to reveal the presence and extent of inflammation in older patients. J Am Geriatr Soc 2000; 48: 1739-1741.
36. Rotstein R, Zeltser D, Shapira I, et al. The usefulness of an inflammation meter to detect the presence of infection/inflammation in elderly patients. J Gerontol A Biol Sci Med Sci 2002; 57: M122-M127.
37. Berliner S, Ben-Ami R, Samocha-Bonet D, et al. The degree of erythrocyte adhesiveness/aggregation in the peripheral blood corresponds to the appearance of inter-erythrocytes adhesive forces. Thromb Res; 2004; 114: 37-44.
38. Ciuffetti G, Pasqualini L, Pirro M, et al. Blood rheology in men with essential hypertension and capillary rarefaction. J Hum Hypertens 2002; 16: 533-537.
39. Lominadze D, Joshua IG, Schuschke DA. Increased erythrocyte aggregation in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 784-789.
40. Hadengue A, Razavian SM, Del-Pino M, Simon A, Levenson J. Influence of sialic acid on erythrocyte aggregation in hypercholesterolemia. Thromb Haemost 1996; 76: 944-949.
41. Hershcovici T, Elishkewitch K, Rotstein R, et al. The erythrocyte adhesiveness/aggregation test to reveal real-time information of rheological relevance in patients with familial and primary hypercholesterolemia before and following plasma exchange. Ther Apher 2002; 6: 140-144.
42. Cicha I, Suzuki Y, Tateishi N, Maeda N. Enhancement of red blood cell aggregation by plasma triglycerides. Clin Hemorheol Microcirc 2001; 24: 247-255.
43. Samocha-Bonet D, Lichtenberg D, Tomer A, et al. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation. Obes Res 2003; 11: 403-407.
44. Schechner V, Shapira I, Berliner S, et al. Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation: a model in hypercholaesterolemic patients. Eur J Clin Invest 2003; 33: 955-961.
45. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
46. Carroll S, Cooke CB, Butterly RJ. Plasma viscosity, fibrinogen and the metabolic syndrome: effect of obesity and cardiorespiratory fitness. Blood Coagul Fibrinolysis 2000; 11 71-78.
47. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
48. Soutani M, Suzuki Y, Tateishi N, Maeda N. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol 1995; 268: H1959-H1965.
49. Schmid-Schonbein H. Blood rheology and physiology of microcirculation. Ric Clin Lab 1981; 11(Suppl. 1): 13-33.
50. Bishop JJ, Nance PR, Popel AS, Intaglietta M, Johson PC. Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol 2001; 280: H222-H236.
51. Mchedlishvili G, Gobejishvili L, Mamaladze A, Momtselidze N, Varazashvili M. Microcirculatory stasis induced by hemorheological disorders: further evidence. Microcirculation 1999; 6: 97-106.
52. Cabel M, Meiselman HJ, Popel AS, Johnson PC. Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol 1997; 272: H1020-H1032.
53. Mchedlishvili G, Shakarishvilli R, Momtselidze N, Gobejishvili L, Aloeva M, Mantskava M. Comparative values of erythrocyte aggregability versus other indices of hemorheological disorders in patients with ischemic brain infarcts. Clin Hemorheol Microcirc 2000; 22: 9-15.
54. Cicha I, Suzuki Y, Tateishi N, Maeda N. Changes of RBC aggregation in oxygenation-deoxygenation: pH dependency and cell morphology. Am J Physiol Heart Circ Physiol 2003; 284: H2335-H2342.
55. Ben Assayag E, Bornstein NM, Shapira I, et al. Inflammation sensitive proteins and erythrocyte aggregation atherothrombosis. Int J Cardiol; in press.
56. Weng X, Cloutier G, Genest J Jr. Contribution of the -455G/A polymorphism at the beta-fibrinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb Haemost 1999; 82 1406-1411.